Cargando…
O-linked mucin-type glycosylation in breast cancer
Changes in mucin-type O-linked glycosylation are seen in over 90% of breast cancers where increased sialylation is often observed and a change from branched glycans to linear glycans is often seen. There are many mechanisms involved including increased/altered expression of glycosyltransferases and...
Autores principales: | Burchell, Joy M., Beatson, Richard, Graham, Rosalind, Taylor-Papadimitriou, Joyce, Tajadura-Ortega, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103458/ https://www.ncbi.nlm.nih.gov/pubmed/29903935 http://dx.doi.org/10.1042/BST20170483 |
Ejemplares similares
-
Understanding and exploiting changes in O-linked glycosylation in breast cancer
por: Julien, S, et al.
Publicado: (2008) -
Latest developments in MUC1 immunotherapy
por: Taylor-Papadimitriou, Joyce, et al.
Publicado: (2018) -
Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers
por: Hadjialirezaei, Soosan, et al.
Publicado: (2017) -
Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers
por: Hadjialirezaei, Soosan, et al.
Publicado: (2018) -
Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
por: Picco, Gianfranco, et al.
Publicado: (2014)